Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
520.00    5.00 (0.97%)
Bid:
510.00
Ask:
530.00
Spread: 20.00 (3.922%)
Market Cap: £85.47m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

AGM Statement

17 Jun 2021 07:00

RNS Number : 1544C
Anpario PLC
17 June 2021
 

17 June 2021

 

Anpario plc("Anpario" or the "Company")

 

AGM Statement

 

Anpario plc, the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity, is holding its AGM later today. Peter Lawrence, Chairman, will make the following comments:

 

"The Board would firstly like to thank all our staff and other stakeholders for their continued efforts in ensuring production and delivery of our products to our customers and subsidiaries around the world especially during this challenging period caused by the Covid 19 pandemic.

 

The Company has delivered good sales and improved profit performance with sales at a similar level to last year, which was a very strong comparative period as customers had increased stock levels at the onset of the pandemic. Most regions are performing to plan with China experiencing a very strong performance, benefiting from last year's ban on anti-biotic growth promoters (AGPs) in animal feed. South East Asia's performance is, however, weaker as countries imposed new lockdowns in response to increasing infection rates and, with less tourism which has reduced overall protein consumption.

 

Our Brexit contingency plans are working well, helping to reduce disruption and we now look forward to our efforts coming to fruition now supported by our European stockholding hub.

 

As with most industries, we are experiencing raw material price inflation and some disruption in our supply chains and global shipping operations. However, we are implementing price increases to help mitigate the increase in costs and our export and logistics team is managing to overcome the logistics issues. We expect these challenges to continue until the last quarter of this year.

 

It is worth noting that Anpario's unique formulation technology also benefits customers as we are able to offer solutions which are more cost effective than alternative competitor products.

 

We are encouraged by some recent business development successes including a large Brazilian poultry integrator using Orego-Stim® and growth in Latin America for our aquaculture products, which are currently being launched in specific countries across Asia. Our exciting growth opportunities and strong balance sheet, which is reflected in our strong cash position, gives me confidence that the Company will continue to develop and grow in the years ahead.

 

Finally, this is my last AGM as I retire from the Board today. I would therefore like to take the opportunity to thank all staff and shareholders for their loyalty and support of Anpario in helping to build a successful company which has delivered significant shareholder value. As I hand over the Chair to Kate Allum, I am confident that the board with its newer members, will successfully continue to steer the company through these unusual times to ensure to deliver value to our shareholders.

 

The Company's interims for the six months period ended 30 June 2021 are expected to be announced on 15 September 2021."

 

 

Enquiries:

Anpario plc

Richard Edwards, Chief Executive Officer

+44 (0)7776 417 129

Karen Prior, Group Finance Director

+44 (0)1909 537 380

Peel Hunt LLP (NOMAD and broker)

+44 (0)20 7418 8900

Adrian Trimmings

Andrew Clark

Will Bell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFLFSERTIRLIL
Date   Source Headline
21st Apr 20157:00 amRNSThe Queen's Award for Enterprise
16th Apr 20158:30 amRNSHolding(s) in Company
24th Mar 20154:24 pmRNSHolding(s) in Company
19th Mar 20154:51 pmRNSBlock Listing Application
18th Mar 20152:35 pmRNSHolding(s) in Company
17th Mar 20153:33 pmRNSIssue of Equity
10th Mar 20151:33 pmRNSDirector/PDMR Shareholding
4th Mar 20157:00 amBUSFinal Results
2nd Feb 20157:00 amRNSTrading Statement
23rd Jan 201510:00 amRNSBlocklisting Interim Review
8th Jan 20154:58 pmRNSHolding(s) in Company
14th Oct 20147:00 amRNSAgreement with Probiotics
6th Oct 20143:16 pmRNSTransaction in Own Shares
17th Sep 20144:31 pmRNSTransaction in Own Shares
11th Sep 20144:37 pmRNSDirector/PDMR Shareholding
10th Sep 20147:00 amBUSHalf-yearly Report
28th Aug 20144:20 pmBUSHolding(s) in Company
14th Jul 20143:02 pmRNSBlock Listing Application
14th Jul 20143:00 pmRNSBlock Listing Application
3rd Jul 20149:26 amBUSHolding(s) in Company
30th Jun 201410:55 amBUSHolding(s) in Company
25th Jun 20144:09 pmBUSHolding(s) in Company
24th Jun 20144:20 pmBUSResult of AGM
24th Jun 20143:36 pmBUSHolding(s) in Company
24th Jun 20147:00 amRNSTrading Statement
12th Jun 201412:03 pmBUSHolding(s) in Company
9th Jun 201411:54 amBUSDirector/PDMR Shareholding
5th Jun 201410:03 amBUSIssue of Equity
20th May 20143:12 pmBUSHolding(s) in Company
12th May 20147:00 amBUSAnnual Financial Report
15th Apr 20144:09 pmBUSHolding(s) in Company
9th Apr 20149:48 amBUSHolding(s) in Company
2nd Apr 20147:00 amBUSFinal Results
24th Feb 20147:00 amRNSAppointment of Peel Hunt as Nomad and Broker
3rd Feb 20147:00 amBUSTrading Statement
28th Jan 20147:00 amRNSDirector's Dealings
27th Jan 201412:06 pmBUSIssue of Equity
17th Jan 20145:10 pmBUSDirector/PDMR Shareholding
14th Jan 20144:39 pmBUSHolding(s) in Company
9th Jan 20147:01 amBUSDirector/PDMR Shareholding
9th Jan 20147:00 amRNSTrading in line with expectations
12th Dec 201310:07 amBUSHolding(s) in Company
6th Dec 20137:00 amRNSU.S. Office
28th Nov 20137:00 amRNSHolding(s) in Company
30th Oct 20133:27 pmRNSHolding(s) in Company
17th Oct 201312:45 pmBUSHolding(s) in Company
15th Oct 201311:31 amBUSHolding(s) in Company
14th Oct 20131:26 pmBUSHolding(s) in Company
30th Sep 20134:25 pmRNSIssue of Equity
27th Sep 20133:50 pmRNSDirector Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.